Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 2Phase 3 2Phase 2/3 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy 1Breast Neoplasms 1

Interventions

Exercise 59Radiotherapy 49Blood Specimen Collection 45Radiosurgery 37Drug Therapy 35Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Control Groups 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19camrelizumab 16Surveys and Questionnaires 16Propofol 16Metformin 16Cytarabine 16anlotinib 15Preoperative Exercise 15Injections 15Fluorouracil 15Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Unknown × Ado-Trastuzumab Emtansine × Clear all
NCT06299852 2024-03-08

Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer

N.N. Petrov National Medical Research Center of Oncology

Phase NA Unknown
58 enrolled
Breast

Breast Neoplasms

NCT05560308 2022-10-03

Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
50 enrolled
Breast

HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡